-
decreased plasma ChE
hepatic disease or inherited abnormal variant
-
Increased ACh in plasma
- -Nephrotic syndrome
- -Liver regeneration
- -AChE inhibition via Organophosphate poisoning
-
-
AST
- -Aspartate Transaminase-
- CM and SkM
- Liver and kidneys
- RBCs
-
increased AST
- **MI and acute viral hepatitis**
- -hemolysis
- -Phsiological in neonates-circulatory failure causing cell death
-
ALT
- -Alanine Transaminase-
- liver
- <SkM and CM
- <kidney
-
Increased ALT
- acute viral hepatitis (marked increase)
- -circ failure
- moderate increase in
- cirrhosis, jaundice, post op CM, SkM disease
-
ALP
- -Alkaline Phosphatase-
- Liver and bone
- ** used as a marker of osteoblast activity**
-
changes in ALP levels
- biliary tract and bone disease
- pregnancy
- infancy and childhood
- high fat meals
-
AP
- -Acid Phosphatase-
- prostate, bone, RBC, platelets
-
LDH
- LDH-1 and 2 = MI
- LDH5 = liver
-
CK
- -creatine kinase-
- CK MM in SkM
- CK MB in CM
- CK BB in brain
- increases can be indicative of tissue damage
-
GGT
- -glutamyl transferase-
- -increased by drug and EtOH induced SER proliferation
- liver, kidney, pancrease
- NOT IN BONE
- **can be used to differentiate tissue of origin of ALP**
-
inc ALP and GGT, AST and ALT wnl
bile duct is point of concern
-
inc AST and ALT, GGT and ALP wnl
liver is point of concern
-
amylase
found mainly in pancrease, increases in serum and urine indicative of pancreatitis
-
reticulocyte count
marker of effective erythropoesis
-
ESR
- -erythrocyte sedimentation rate-
- measure acute phase response
-
polychromasia
- increased reticulocytes
- -large multicolor RBC caused by persistance of RNA
-
spherocyte
- RBC without biconcavity, hyperchromia and decreased size
- -AI hemolytic anemia or hereditary
- -hereditary spherocytosis caused by non functioning spektrin of ankyrin
-
drepanocyte
sickle cell RBC
-
Dacrocyte
- Tear drop RBC
- - caused by bone marrow infiltration or myelofibrosis
-
schistocyte
fragmented RBC caused by hemolytic anemia or any RBC b/d
-
target cells
- bulls eye cells
- -thallesemia, Fe def anemia, EtOH liver disease
-
punctate basophilia
- -course basophilic stippling-
- -lead poisoning
-
HJ bodies
- -purple nuclear DNA
- -non functioning spleen
-
Heinz bodies
- -particles of denatured Hb on inner face
- -G6PD defeciency
-
siderocytes
- Fe granules not bound to Hb
- -Fe overload-
-
alpha 1 globulins
- a1 antitrypsin (lung)
- a- lipoprotein
-
a2 globulins
- haptoglobin
- ceruplasmin
- a2 macroglobulin (protease inhibitor all over body)
-
-
-
-
increase bleeding time
- - platelet disorders
- - vWF deficiency
- - ASA
- - uremia
-
increased PT
- - F7 (extrinsinc pw)
- - F10,5 , 2 and 1 (common pw)
- -warfarin therapy
-
increased PTT
- - F11, 9, 8 (intrinsic p/w) (F12 affected, but not significant)
- - F10, 5, 2, 1 (common p/w)
- - heparin therapy
-
Vit K requiring factors
- - F2, 7, 9, 10
- (platelet PM bound)
-
Testing Fe status
- - serum ferratin
- -TIBC (total iron binding capacity)
-
UDP-glucuronyl Transferase
Liver enzyme that conjugates
-
differentiation b/t non-hemolytic anemia and hemolytic anemia
- reticulocyte count< 3% = NON hemolytic
- reticulocyte count > 3%= hemolytic
-
sarcoma
- - malignant cancer of mesenchymal origin
- - spreads via blood
- - poor prognosis
-
carcinoma
- - malignant cancer of epithelial origin
- - spreads via lymph
- - better prognosis
|
|